ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 175 filers reported holding ANI PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 0.82 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,466,273 | +127.2% | 42,478 | +110.7% | 0.00% | +100.0% |
| Q2 2023 | $1,085,374 | +129.8% | 20,163 | +69.5% | 0.00% | +100.0% |
| Q1 2023 | $472,390 | -4.6% | 11,893 | -3.3% | 0.00% | 0.0% |
| Q4 2022 | $494,950 | +23.7% | 12,303 | -1.2% | 0.00% | 0.0% |
| Q3 2022 | $400,000 | +0.5% | 12,453 | -7.3% | 0.00% | 0.0% |
| Q2 2022 | $398,000 | -19.3% | 13,428 | -23.4% | 0.00% | 0.0% |
| Q1 2022 | $493,000 | -33.1% | 17,538 | +9.7% | 0.00% | 0.0% |
| Q4 2021 | $737,000 | -15.1% | 15,988 | -39.6% | 0.00% | 0.0% |
| Q3 2021 | $868,000 | -40.9% | 26,459 | -36.8% | 0.00% | -50.0% |
| Q2 2021 | $1,468,000 | -40.2% | 41,886 | -38.3% | 0.00% | -50.0% |
| Q1 2021 | $2,455,000 | +100.1% | 67,918 | +60.8% | 0.00% | +100.0% |
| Q4 2020 | $1,227,000 | +256.7% | 42,233 | +246.7% | 0.00% | +100.0% |
| Q3 2020 | $344,000 | -11.6% | 12,183 | +1.2% | 0.00% | 0.0% |
| Q2 2020 | $389,000 | -35.7% | 12,040 | -19.0% | 0.00% | 0.0% |
| Q1 2020 | $605,000 | -35.0% | 14,857 | -1.6% | 0.00% | 0.0% |
| Q4 2019 | $931,000 | -15.7% | 15,098 | -0.3% | 0.00% | -50.0% |
| Q3 2019 | $1,104,000 | -28.6% | 15,148 | -19.5% | 0.00% | 0.0% |
| Q2 2019 | $1,547,000 | +17.1% | 18,818 | +0.4% | 0.00% | 0.0% |
| Q1 2019 | $1,321,000 | +66.2% | 18,737 | +6.2% | 0.00% | +100.0% |
| Q4 2018 | $795,000 | -24.0% | 17,649 | -4.6% | 0.00% | -50.0% |
| Q3 2018 | $1,046,000 | -21.8% | 18,492 | -7.6% | 0.00% | 0.0% |
| Q2 2018 | $1,338,000 | +41.6% | 20,022 | +23.4% | 0.00% | +100.0% |
| Q1 2018 | $945,000 | -2.6% | 16,222 | +7.8% | 0.00% | 0.0% |
| Q4 2017 | $970,000 | +21.4% | 15,050 | -1.2% | 0.00% | 0.0% |
| Q3 2017 | $799,000 | +22.4% | 15,230 | +9.2% | 0.00% | 0.0% |
| Q2 2017 | $653,000 | -6.3% | 13,950 | -0.9% | 0.00% | 0.0% |
| Q1 2017 | $697,000 | -17.1% | 14,080 | +1.4% | 0.00% | 0.0% |
| Q4 2016 | $841,000 | -13.0% | 13,880 | -4.7% | 0.00% | -50.0% |
| Q3 2016 | $967,000 | -7.4% | 14,570 | -22.1% | 0.00% | 0.0% |
| Q2 2016 | $1,044,000 | +68.4% | 18,700 | +1.6% | 0.00% | +100.0% |
| Q1 2016 | $620,000 | -23.7% | 18,410 | +2.2% | 0.00% | 0.0% |
| Q4 2015 | $813,000 | +11.8% | 18,010 | -2.2% | 0.00% | 0.0% |
| Q3 2015 | $727,000 | -38.4% | 18,410 | -3.3% | 0.00% | -50.0% |
| Q2 2015 | $1,181,000 | +1.9% | 19,030 | +2.7% | 0.00% | 0.0% |
| Q1 2015 | $1,159,000 | – | 18,530 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FIRST WILSHIRE SECURITIES MANAGEMENT INC | 327,929 | $9,218,000 | 3.24% |
| Parkman Healthcare Partners LLC | 107,911 | $3,033,000 | 0.89% |
| Global Alpha Capital Management Ltd. | 350,231 | $9,845,000 | 0.85% |
| MARATHON CAPITAL MANAGEMENT | 75,010 | $2,109,000 | 0.60% |
| TANG CAPITAL MANAGEMENT LLC | 100,000 | $2,811,000 | 0.56% |
| EMERALD ADVISERS, LLC | 354,045 | $9,952,000 | 0.38% |
| Sio Capital Management, LLC | 40,000 | $1,124,000 | 0.37% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 299,493 | $8,419,000 | 0.37% |
| Stonepine Capital Management, LLC | 26,060 | $733,000 | 0.30% |
| Mitsubishi UFJ Asset Management (UK) Ltd. | 23,000 | $646,530,000 | 0.29% |